Avail Clinical Research Announces Research Studies in DeLand, Florida For Teenage Smoking Cessation

April 13, 2011 - PRLog -- DeLand, Florida— Privately owned research facility, Avail Clinical Research, will be conducting several research studies to test possible treatment options to help with Smoking Cessation. Avail was founded in 1988 in DeLand, Florida. "Through clinical research studies, we can strive to significantly build on data previously conducted on those currently diagnosed with smoking cessation," says Bruce G. Rankin, DO, CPI, the Medical Director and Principal Investigator at Avail Clinical Research since 1999. "Treatments for smoking cessation are one of the research studies we are pleased to continue with at Avail Clinical Research. Our systemic evaluation clinical research trials are designed specifically to test the safety and efficacy of treatments for humans."

The research studies will enroll those already diagnosed with smoking cessation. Avail Clinical Research is searching for volunteers who:

- have a really strong desire to quit smoking (study is a year long and comes with counseling to help people quit permanently)
- willing to use a tobacco alternative (study offers a random selection of SNUS or lozenges as the tobacco alternative)
- are 21 or older
- currently smoke more than 10 cigarettes a day
- are not obese
- do not have any of the following: Diabetes, HIV, Hep B, Hep C

Avail Clinical Research conducts clinical trials for diabetes, COPD, gout, OsteoArthritis and other conditions. Located in DeLand, Florida, near Orlando and Daytona Beach. Participation may include medical care.